Frederic Guerard - 19 Aug 2026 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Reporting relationship: Director
Issuer ticker: CALC
Reported as of: 19 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Aug 2026, 18:45:54 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ John Dunn, Attorney-in-Fact

Key filing fact

Frederic Guerard filed Form 4 for CalciMedica, Inc. (CALC) on 21 Aug 2026.

Key facts

This page summarizes Frederic Guerard's Form 4 filing for CalciMedica, Inc. (CALC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Aug 2026, 18:45.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001825009 Primary reporting owner

Guerard Frederic

Relationship: Director
Address: C/O CALCIMEDICA, INC., 505 COAST S. BLVD, #202, LA JOLLA
Signature: /s/ John Dunn, Attorney-in-Fact
Signature date: 21 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CALC transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value
Shares: +10,000
Change %
Price: $0.000000^*
Shares after: 10,000
Date: 19 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $0.6131
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc.